Company Filing History:
Years Active: 2009
Title: Federico Calvani: Innovator in Pharmaceutical Chemistry
Introduction
Federico Calvani is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of bradykinin antagonists. His work has implications for various medical disorders, showcasing the importance of innovation in healthcare.
Latest Patents
Calvani holds a patent for "Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom." This patent describes non-peptide compounds characterized by the presence of an alpha, alpha-disubstituted amino acid with at least one amino group, either free or salified, or the corresponding ammonium quaternary salt. These compounds act as specific antagonists of the bradykinin (BK) B2 receptor. The BK receptor antagonists represent a novel class of medicaments that can be utilized in treating disorders associated with these receptors. He has 1 patent to his name.
Career Highlights
Calvani is currently employed at Menarini Ricerche S.p.a., where he continues to advance his research in pharmaceutical innovations. His work at Menarini has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Fernando Catrambone and Patrizia Felicetti. Their collaborative efforts contribute to the innovative environment at Menarini Ricerche S.p.a., fostering advancements in pharmaceutical research.
Conclusion
Federico Calvani's contributions to the field of pharmaceutical chemistry, particularly through his patent on bradykinin antagonists, highlight the vital role of inventors in advancing medical science. His work not only showcases his expertise but also emphasizes the importance of collaboration in driving innovation forward.